Xenon Pharmaceuticals Inc.

(XENE) Trade

By |

Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 81
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 13.45 $ 0.35 (2.67%)
Last Price 13.45 Change $ 0.35 Change % 2.67 Tick N/A
Bid 13.35 Bid Size 400.00 Ask 13.45 Ask Size 300.00
Open 12.95 High 13.45 Low 12.70 Prev Close 13.10
Last Trade Volume 112,429 52 Wk Hi 15.92 52 Wk Low 2.10
Market Cap 276.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,561,889.00 EPS (TTM) -1.54 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 42
Number of Buys 1 35
Number of Sells 4 7
Net Activity -2431626 -2092506
Last 10 Buys Shares
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Raymond J. Winquist 1,000
Mohammad Azab 1,000
James R. Empfield 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Michael Hayden 1,000
Last 10 Sell Shares
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1